Clinical Outcomes of Off-Label Dosing of Direct Oral Anticoagulant Therapy Among Japanese Patients With Atrial Fibrillation Identified From the SAKURA AF Registry

被引:66
作者
Murata, Nobuhiro [1 ]
Okumura, Yasuo [1 ]
Yokoyama, Katsuaki [2 ]
Matsumoto, Naoya [2 ]
Tachibana, Eizo [3 ]
Kuronuma, Keiichiro [3 ]
Oiwa, Koji [4 ]
Matsumoto, Michiaki [4 ]
Kojima, Toshiaki [5 ]
Hanada, Shoji [6 ]
Nomoto, Kazumiki [7 ]
Arima, Ken [8 ]
Takahashi, Fumiyuki [9 ]
Kotani, Tomobumi [10 ]
Ikeya, Yukitoshi [11 ]
Fukushima, Seiji [12 ]
Itoh, Satoru [13 ]
Kondo, Kunio [14 ]
Chiku, Masaaki [15 ]
Ohno, Yasumi [16 ]
Onikura, Motoyuki [17 ]
Hirayama, Atsushi [1 ]
Hirayama, A. [18 ,19 ]
Okumura, Y. [18 ]
Kunimoto, S. [18 ]
Okumura, Y. [18 ]
Kato, M. [18 ]
Udagawa, S. [19 ]
Hirayama, A. [18 ,19 ]
Okumura, Y. [18 ]
Watanabe, I [18 ]
Hiro, T. [18 ]
Takayama, T. [18 ]
Kunimoto, S. [18 ]
Nakai, T. [18 ]
Kato, M. [18 ]
Yokoyama, K. [2 ]
Ikeda, A. [2 ]
Matsumoto, N. [2 ]
Tachibana, E. [3 ]
Kuronuma, K. [3 ]
Oiwa, K. [4 ]
Matsumoto, M. [4 ]
Nishida, T. [4 ]
Kojima, T. [5 ]
Ichikawa, M. [5 ]
Hanada, S. [20 ]
Nomoto, K. [7 ]
Tosaka, T. [7 ]
Sonoda, K. [7 ]
机构
[1] Nihon Univ, Itabashi Hosp, Div Cardiol, Tokyo, Japan
[2] Nihon Univ Hosp, Dept Cardiol, Tokyo, Japan
[3] Kawaguchi Municipal Med Ctr, Saitama, Japan
[4] Yokohama Chuo Hosp, Yokohama, Kanagawa, Japan
[5] Sekishindo Hosp, Saitama, Japan
[6] TMG Asaka Med Ctr, Saitama, Japan
[7] Tokyo Rinkai Hosp, Tokyo, Japan
[8] Kasukabe Med Ctr, Saitama, Japan
[9] Yasuda Hosp, Tokyo, Japan
[10] Makita Gen Hosp, Tokyo, Japan
[11] Itabashi Med Assoc Hosp, Tokyo, Japan
[12] Ukima Cent Hosp, Tokyo, Japan
[13] Itou Cardiovasc Clin, Saitama, Japan
[14] Kondo Clin, Tokyo, Japan
[15] Keiai Clin, Tokyo, Japan
[16] Ohno Med Clin, Tokyo, Japan
[17] Onikura Clin, Chiba, Japan
[18] Nihon Univ, Div Cardiol, Dept Med, Sch Med, Tokyo, Japan
[19] Nihon Univ, Dept Math, Sch Med, Tokyo, Japan
[20] Asakadai Cent Gen Hosp, Asaka, Saitama, Japan
[21] Kasukabe Municipal Hosp, Kasukabe, Saitama, Japan
[22] Kobari Gen Clin, Noda, Chiba, Japan
[23] Chikuma Cent Hosp, Nagano, Japan
[24] Yamada Clin, Nishio, Aichi, Japan
[25] Higashi Saitama Gen Hosp, Satte, Saitama, Japan
[26] Zengyodanchi Ishikawa Clin, Yokohama, Kanagawa, Japan
[27] Tokutake Clin, Saitama, Japan
[28] Sugino Clin, Hiroshima, Japan
[29] Yokohama Sotetsu Bldg Clin, Yokohama, Kanagawa, Japan
[30] Suzuki Clin, Tokyo, Japan
[31] Fujita Clin, Tokyo, Japan
[32] Yumikura Clin, Tokyo, Japan
[33] Keiai Hosp, Fujimi, Saitama, Japan
[34] Sekimachi Med Clin, Tokyo, Japan
[35] Tokiwadai Surg Hosp, Tokyo, Japan
[36] Hikarigaoka Clin, Kashiwa, Chiba, Japan
[37] Osuga Clin, Hamamatsu, Shizuoka, Japan
[38] Nakai Clin, Tokyo, Japan
[39] Kurumatani Clin, Tokyo, Japan
[40] Horinaka Hosp, Satte, Saitama, Japan
[41] Nasu Red Cross Hosp, Otawara, Tochigi, Japan
[42] Sato Clin, Hiroshima, Japan
[43] Kofune Clin, Tokyo, Japan
[44] Ikebukuro Okubo Clin, Tokyo, Japan
[45] Minami Machida Hosp, Machida, Tokyo, Japan
[46] Ishii Clin, Izumisano, Osaka, Japan
[47] Akabane Cent Hosp, Tokyo, Japan
[48] Hirose Clin, Suzuka, Mie, Japan
[49] Sekimoto Mem Hosp, Kawagoe, Saitama, Japan
[50] Matsumura Clin, Hirakata, Osaka, Japan
关键词
Atrial fibrillation; Direct oral anticoagulants; Off-label dose therapy; ISCHEMIC-STROKE; VS; WARFARIN; RISK; RIVAROXABAN; DABIGATRAN; APIXABAN; EDOXABAN; EFFICACY; SAFETY;
D O I
10.1253/circj.CJ-18-0991
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Off-label dosing of direct oral anticoagulants (DOACs) is encountered clinically among patients with atrial fibrillation (AF), although data on the clinical outcomes of over-and under-dosing are lacking in Japan. Methods and Results: We examined the clinical outcomes of off-label DOAC dosing using the SAKURA AF Registry, a prospective multicenter registry in Japan. Among 3,237 enrollees, 1,676 under any of the 4 DOAC regimens were followed up for a median of 39.3 months: 746 (45.0%), appropriate standard-dose; 477 (28.7%), appropriate low-dose; 66 (4.0%), over-dose; and 369 (22.2%) under-dose. Compared with the standard-dose group, patients in the under-and over-dose groups were significantly older and had a higher stroke risk. After multivariate adjustment, stroke/systemic embolism (SE) and death events were equivalent between the standard-and under-dose groups, but major bleeding events tended to be lower in the under-dose group (hazard ratio [HR] 0.474, P=0.0739). Composite events (stroke/SE, major bleeding, or death) were higher in the over-dose than in the standard-dose group (HR 2.714, P=0.0081). Conclusions: Clinical outcomes were not worse for under-dose than for standard-dose users among patients with different backgrounds. Over-dose users, however, were at higher risk for all clinical events and required careful follow-up. Further studies are needed to clarify the safety and effectiveness of off-label DOAC dosing in Japan.
引用
收藏
页码:727 / +
页数:11
相关论文
共 27 条
[1]   Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis [J].
Bhatt, Deepak L. ;
Eagle, Kim A. ;
Ohman, E. Magnus ;
Hirsch, Alan T. ;
Goto, Shinya ;
Mahoney, Elizabeth M. ;
Wilson, Peter W. F. ;
Alberts, Mark J. ;
D'Agostino, Ralph ;
Liau, Chiau-Suong ;
Mas, Jean-Louis ;
Roether, Joachim ;
Smith, Sidney C., Jr. ;
Salette, Genevieve ;
Contant, Charles F. ;
Massaro, Joseph M. ;
Steg, Ph. Gabriel .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (12) :1350-1357
[2]   Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].
Connolly, Stuart J. ;
Ezekowitz, Michael D. ;
Yusuf, Salim ;
Eikelboom, John ;
Oldgren, Jonas ;
Parekh, Amit ;
Pogue, Janice ;
Reilly, Paul A. ;
Themeles, Ellison ;
Varrone, Jeanne ;
Wang, Susan ;
Alings, Marco ;
Xavier, Denis ;
Zhu, Jun ;
Diaz, Rafael ;
Lewis, Basil S. ;
Darius, Harald ;
Diener, Hans-Christoph ;
Joyner, Campbell D. ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151
[3]   Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial [J].
Eikelboom, John W. ;
Wallentin, Lars ;
Connolly, Stuart J. ;
Ezekowitz, Mike ;
Healey, Jeff S. ;
Oldgren, Jonas ;
Yang, Sean ;
Alings, Marco ;
Kaatz, Scott ;
Hohnloser, Stefan H. ;
Diener, Hans-Christoph ;
Franzosi, Maria Grazia ;
Huber, Kurt ;
Reilly, Paul ;
Varrone, Jeanne ;
Yusuf, Salim .
CIRCULATION, 2011, 123 (21) :2363-U72
[4]   Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation [J].
Gage, BF ;
Waterman, AD ;
Shannon, W ;
Boechler, M ;
Rich, MW ;
Radford, MJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (22) :2864-2870
[5]   Edoxaban versus Warfarin in Patients with Atrial Fibrillation [J].
Giugliano, Robert P. ;
Ruff, Christian T. ;
Braunwald, Eugene ;
Murphy, Sabina A. ;
Wiviott, Stephen D. ;
Halperin, Jonathan L. ;
Waldo, Albert L. ;
Ezekowitz, Michael D. ;
Weitz, Jeffrey I. ;
Spinar, Jindrich ;
Ruzyllo, Witold ;
Ruda, Mikhail ;
Koretsune, Yukihiro ;
Betcher, Joshua ;
Shi, Minggao ;
Grip, Laura T. ;
Patel, Shirali P. ;
Patel, Indravadan ;
Hanyok, James J. ;
Mercuri, Michele ;
Vogelmann, O. ;
Gonzalez, C. ;
Ahuad Guerrero, R. ;
Rodriguez, M. ;
Albisu, J. ;
Rosales, E. ;
Allall, O. ;
Reguero, M. ;
Alvarez, C. ;
Garcia, M. ;
Ameriso, S. ;
Ameriso, P. ;
Amuchastegui, M. ;
Caceres, M. ;
Beloscar, J. ;
Petrucci, J. ;
Berli, M. ;
Budassi, N. ;
Valle, M. ;
Bustamante Labarta, G. ;
Saravia, M. ;
Caccavo, A. ;
Fracaro, V. ;
Cartasegna, L. ;
Novas, V. ;
Caruso, O. ;
Saa Zarandon, R. ;
Colombo, H. ;
Morandini, M. ;
Cuello, J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (22) :2093-2104
[6]   Efficacy and Safety of Apixaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation from East Asia: A Subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial [J].
Goto, Shinya ;
Zhu, Jun ;
Liu, Lisheng ;
Oh, Byung-Hee ;
Wojdyla, Daniel M. ;
Aylward, Philip ;
Bahit, M. Cecilia ;
Gersh, Bernard J. ;
Hanna, Michael ;
Horowitz, John ;
Lopes, Renato D. ;
Wallentin, Lars ;
Xavier, Denis ;
Alexander, John H. .
AMERICAN HEART JOURNAL, 2014, 168 (03) :303-309
[7]   Apixaban versus Warfarin in Patients with Atrial Fibrillation [J].
Granger, Christopher B. ;
Alexander, John H. ;
McMurray, John J. V. ;
Lopes, Renato D. ;
Hylek, Elaine M. ;
Hanna, Michael ;
Al-Khalidi, Hussein R. ;
Ansell, Jack ;
Atar, Dan ;
Avezum, Alvaro ;
Cecilia Bahit, M. ;
Diaz, Rafael ;
Easton, J. Donald ;
Ezekowitz, Justin A. ;
Flaker, Greg ;
Garcia, David ;
Geraldes, Margarida ;
Gersh, Bernard J. ;
Golitsyn, Sergey ;
Goto, Shinya ;
Hermosillo, Antonio G. ;
Hohnloser, Stefan H. ;
Horowitz, John ;
Mohan, Puneet ;
Jansky, Petr ;
Lewis, Basil S. ;
Luis Lopez-Sendon, Jose ;
Pais, Prem ;
Parkhomenko, Alexander ;
Verheugt, Freek W. A. ;
Zhu, Jun ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (11) :981-992
[8]   Predictive factors for bleeding during treatment with rivaroxaban and warfarin in Japanese patients with atrial fibrillation - Subgroup analysis of J-ROCKET AF [J].
Hori, Masatsugu ;
Matsumoto, Masayasu ;
Tanahashi, Norio ;
Momomura, Shin-ichi ;
Uchiyama, Shinichiro ;
Goto, Shinya ;
Izumi, Tohru ;
Koretsune, Yukihiro ;
Kajikawa, Mariko ;
Kato, Masaharu ;
Cavaliere, Mary ;
Iekushi, Kazuma ;
Yamanaka, Satoshi .
JOURNAL OF CARDIOLOGY, 2016, 68 (5-6) :523-528
[9]   Dabigatran Versus Warfarin Effects on Ischemic and Hemorrhagic Strokes and Bleeding in Asians and Non-Asians With Atrial Fibrillation [J].
Hori, Masatsugu ;
Connolly, Stuart J. ;
Zhu, Jun ;
Liu, Li Sheng ;
Lau, Chu-Pak ;
Pais, Prem ;
Xavier, Denis ;
Kim, Sung Soon ;
Omar, Razali ;
Dans, Antonio L. ;
Tan, Ru San ;
Chen, Jyh-Hong ;
Tanomsup, Supachai ;
Watanabe, Mitsunori ;
Koyanagi, Masahide ;
Ezekowitz, Michael D. ;
Reilly, Paul A. ;
Wallentin, Lars ;
Yusuf, Salim .
STROKE, 2013, 44 (07) :1891-+
[10]   Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation - The J-ROCKET AF Study [J].
Hori, Masatsugu ;
Matsumoto, Masayasu ;
Tanahashi, Norio ;
Momomura, Shin-ichi ;
Uchiyama, Shinichiro ;
Goto, Shinya ;
Izumi, Tohru ;
Koretsune, Yukihiro ;
Kajikawa, Mariko ;
Kato, Masaharu ;
Ueda, Hitoshi ;
Iwamoto, Kazuya ;
Tajiri, Masahiro .
CIRCULATION JOURNAL, 2012, 76 (09) :2104-2111